Ace Alkaline Phosphatase Reagent, Amylase Reagent, Alt Reagent, Ast Reagent
Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes. 510(k) K131351, from Alfa Wassermann Diagnostic Technologies, LLC (West Caldwell, NJ). Product code CJE, class 2.
As of Nov 20, 2026, K131351 is an FDA 510(k) held by Alfa Wassermann Diagnostic Technologies, LLC, substantially equivalent on Aug 15, 2013 after 97 days, with 1 recall tied to it in FDA's recall database.
- Review time: 97 days
- Recalls: 1
The ACE Amylase Reagent is intended for the quantitative determination of \alpha -amylase activity in serum and lithium heparin plasma using the ACE, ACE Alera, and ACE Axcel Clinical Chemistry Systems. Amylase measurements are used primarily for the diagnosis and treatment of pancreatitis (inflammation of the pancreas).
- Ace Clinical Chemistry SystemK931786 · Schiapparelli Biosystems, Inc. · Sep 21, 1993
- Ace Clinical Chemistry SystemK930104 · Schiapparelli Biosystems, Inc. · Aug 23, 1993
| Started | Recall | Status |
|---|---|---|
| Mar 5, 2014 | Z-1529-2014Extremely low absorbance readings. | Terminated |
- Tru Liver Health Test PanelK251074 · Truvian Health · Dec 19, 2025
- Alkaline PhosphataseK240468 · Abbott Laboratories Diagnostics Division · Oct 16, 2024
- Alkaline Phosphatase2K223317 · Abbott Ireland Diagnostics Division · Jul 21, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 10, 2013
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files